| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.087 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |